Found 0 matching trials
Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors PHASE2 Background:
-Some people with wild-type gastrointestinal stromal tumors (W...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib PHASE1 Study in Healthy Volunteers to Assess the Pharmacokinetics of Metformin Adm...
Show More Learn More & Join Trial
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer PHASE2 Open label multicentric phase II randomized trial, using high throughput ge...
Show More Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Learn More & Join Trial
Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer PHASE3 Primary Objective:
To determine the efficacy (as assessed by progression-f...
Show More Learn More & Join Trial
Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer PHASE2 A randomised double blind placebo controlled phase II study of fulvestrant ...
Show More Location
Royal Bournemouth Hospital
Learn More & Join Trial
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) PHASE1 Background:
* The combination of anti-cancer drugs vandetanib (given orall...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With Vandetanib PHASE1 This is a study in healthy volunteers to assess the pharmacokinetics (PK) o...
Show More Learn More & Join Trial
Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma PHASE1 The phase I trial aims to determine the recommended phase II dose (RP2D) of...
Show More Location
Guy's and St Thomas' NHS Foundation Trust
Learn More & Join Trial
Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery PHASE2 RATIONALE: Vandetanib may stop the growth of tumor cells by blocking some o...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer PHASE2 Participants will have been diagnosed with advanced progressive thyroid can...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial